Delivery Order SPE2DB20D1109-SPE2DB25FP84P
Award Date 9/26/25
Potential Completion Date 10/20/25
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $6,433.40 to AmerisourceBergen Drug Corp for the supply of Praxbind (idarucizumab) 5G dose in 2x 2.5G/50ML vials, with a firm fixed-price contract type and an ultimate completion date of October 1, 2025. This award, issued on September 10, 2025, represents a non-set-aside, competitively awarded contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,216.70 to AmerisourceBergen Drug Corp for the supply of Idarucizumab 2.5GM 2S, a reversal agent used in emergency medicine. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $2,881.90 firm fixed-price contract is for the supply of PRAXBIND 5G DOSE (2X 2.5G/50ML) 50ML, a pharmaceutical product. The delivery order is issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award, with ID SPE2DB22D3301|SPE2DB24FY4PW, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of the global pharmaceutical company Amerisourcebergen Corporation. The $11,527.60 firm fixed price delivery order is for the supply of PRAXBIND 5G DOSE (2X 2.5G/50ML) 50ML, a pharmaceutical product, with a period of performance through May 3, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of IDARUCIZUMAB 2.5GM 2S, a medical product. The contract has a ceiling value of $3,216.70 and a period of performance ending on July 31, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Pradaxa 150 mg capsules (60-count units) with a ceiling value of $1,960.47. This firm fixed price delivery order, which has an ultimate completion date of August 4, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- This is a $6,433.40 Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IDARUCIZUMAB 2.5GM 2S, a medical product, with a performance period through June 26, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,045.72 fixed-price delivery order is for the procurement of Pradaxa 150 mg capsules. The contract has an ultimate completion date of October 16, 2023 and was awarded on October 13, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
- The U.S. Defense Logistics Agency (DLA) awarded a $37,269.81 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division. The order is for the supply of PRADAXA 150 MG CAPSULE UU 60S, a pharmaceutical product, with a completion date of September 4, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Andexxa 200 mg vials, a critical reversal agent used in emergency medical settings. This firm fixed-price delivery order, valued at $8,672.15, represents a competitive award with no set-aside designation and is scheduled for completion by May 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office operations in Conshohocken,...